应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LH 徕博科
盘前交易 02-19 08:51:36 EST
246.29
-0.20
-0.08%
盘前
246.49
+0.20
+0.08%
08:29 EST
最高
247.18
最低
244.12
成交量
37.28万
今开
245.23
昨收
246.49
日振幅
1.24%
总市值
205.41亿
流通市值
204.46亿
总股本
8,340万
成交额
9,178万
换手率
0.45%
流通股本
8,301万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
路透中文 · 02-12
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
路透中文 · 02-12
美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司
徕博科2024财年实现净利润7.46亿美元,同比增加96.83%
市场透视 · 02-09
徕博科2024财年实现净利润7.46亿美元,同比增加96.83%
巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由271.00美元调整至260.00美元。
金融界 · 02-07
巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由271.00美元调整至260.00美元。
杰富瑞投资银行:维持Labcorp Holdings(LH.US)评级,由买入调整至买入评级, 目标价由275.00美元调整至290.00美元。
金融界 · 02-06
杰富瑞投资银行:维持Labcorp Holdings(LH.US)评级,由买入调整至买入评级, 目标价由275.00美元调整至290.00美元。
Labcorp第四季度财报:收入和每股收益超预期,预计2025年将实现强劲增长,分析师重申“表现优异”评级
财报速递 · 02-06
Labcorp第四季度财报:收入和每股收益超预期,预计2025年将实现强劲增长,分析师重申“表现优异”评级
Labcorp Holdings Inc 报告截至 12 月 31 日的季度业绩 - 盈利摘要
路透中文 · 02-06
Labcorp Holdings Inc 报告截至 12 月 31 日的季度业绩 - 盈利摘要
实验室公司2024年第四季度调整后每股收益为3.45美元,超过预期的3.39美元,销售额为33.3亿美元,超过预期的33.1亿美元
财报速递 · 02-06
实验室公司2024年第四季度调整后每股收益为3.45美元,超过预期的3.39美元,销售额为33.3亿美元,超过预期的33.1亿美元
Labcorp预计2025年销售额为138.8亿至140.5亿美元,对比市场预期的137.9亿美元,调整后每股收益为15.60至16.40美元,对比市场预期的16.02美元
财报速递 · 02-06
Labcorp预计2025年销售额为138.8亿至140.5亿美元,对比市场预期的137.9亿美元,调整后每股收益为15.60至16.40美元,对比市场预期的16.02美元
由于诊断检测需求旺盛,Labcorp 预测 2025 年收入高于预期
路透中文 · 02-06
由于诊断检测需求旺盛,Labcorp 预测 2025 年收入高于预期
巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由249.00美元调整至271.00美元。
金融界 · 02-03
巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由249.00美元调整至271.00美元。
BUZZ-Quest 季度业绩超出预期,创三年新高
路透中文 · 01-30
BUZZ-Quest 季度业绩超出预期,创三年新高
徕博科盘中异动 大幅上涨5.02%
市场透视 · 01-30
徕博科盘中异动 大幅上涨5.02%
联环药业(600513.SH):1类新药LH-1801片Ⅲ期联合二甲双胍临床试验完成受试者入组
智通财经 · 01-20
联环药业(600513.SH):1类新药LH-1801片Ⅲ期联合二甲双胍临床试验完成受试者入组
Evercore ISI Group:上调Labcorp Holdings评级
证券之星 · 01-07
Evercore ISI Group:上调Labcorp Holdings评级
Evercore ISI Group:上调Labcorp Holdings(LH.US)评级,由大市同步调整至优于大市评级, 目标价由260.00美元调整至265.00美元。
金融界 · 01-07
Evercore ISI Group:上调Labcorp Holdings(LH.US)评级,由大市同步调整至优于大市评级, 目标价由260.00美元调整至265.00美元。
Cinven 获意大利批准向 Labcorp 出售 Synlab 少数股权
路透中文 · 2024-11-20
Cinven 获意大利批准向 Labcorp 出售 Synlab 少数股权
美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛
Reuters · 2024-11-20
美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛
BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休
路透中文 · 2024-11-19
BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休
徕博科2024财年第三财季实现净利润1.69亿美元,同比减少7.65%
市场透视 · 2024-10-31
徕博科2024财年第三财季实现净利润1.69亿美元,同比减少7.65%
加载更多
公司概况
公司名称:
徕博科
所属市场:
NYSE
上市日期:
--
主营业务:
Labcorp Holdings Inc.是特拉华州的一家公司,成立于1971年。公司是一家领先的全球生命科学公司,已在指导患者护理方面深入整合。公司通过其LabCorp诊断(LCD)和Covance药物开发(CDD)部门提供全面的临床实验室和端到端药物开发服务。LabCorp定位于研究和护理交付的融合,以实现更精确和个性化的医疗保健,将世界一流的诊断和药物开发能力结合在一起。
发行价格:
--
{"stockData":{"symbol":"LH","market":"US","secType":"STK","nameCN":"徕博科","latestPrice":246.29,"timestamp":1739912400000,"preClose":246.49,"halted":0,"volume":372760,"hourTrading":{"tag":"盘前","latestPrice":246.49,"preClose":246.29,"latestTime":"08:29 EST","volume":700,"amount":172306.792,"timestamp":1739971751549},"delay":0,"floatShares":83014983,"shares":83400000,"eps":8.84,"marketStatus":"盘前交易","change":-0.2,"latestTime":"02-19 08:51:36 EST","open":245.23,"high":247.18,"low":244.12,"amount":91784225.1224,"amplitude":0.012414,"askPrice":247.29,"askSize":2,"bidPrice":242.21,"bidSize":53,"shortable":3,"etf":0,"ttmEps":8.84,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1739975400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":672379200000,"exchange":"NYSE","adjPreClose":246.29,"dividendRate":0.011694,"preHourTrading":{"tag":"盘前","latestPrice":246.49,"preClose":246.29,"latestTime":"08:29 EST","volume":700,"amount":172306.792,"timestamp":1739971751549},"postHourTrading":{"tag":"盘后","latestPrice":246.29,"preClose":246.29,"latestTime":"18:04 EST","volume":53078,"amount":13072611.15,"timestamp":1739919875628},"volumeRatio":0.64542832767888,"impliedVol":0.2098,"impliedVolPercentile":0.124},"requestUrl":"/m/hq/s/LH","defaultTab":"news","newsList":[{"id":"2510345749","title":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2510345749","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510345749?lang=zh_cn&edition=full","pubTime":"2025-02-12 15:21","pubTimestamp":1739344887,"startTime":"0","endTime":"0","summary":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司路透2月12日 - 华尔街证券分析师周三修订了对爱迪生国际、Onestream 和 Vertex Pharmaceuticals 等几家美国上市公司的评级和目标价。要点 * 爱迪生国际EIX.N:摩根大通给予其中性评级 * Molina Healthcare Inc MOH.N:摩根大通将目标价从350美元下调至333美元 * Onestream Inc OS.O:摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Vertex Pharmaceuticals Inc VRTX.O:Canaccord Genuity将其评级从 \"卖出 \"上调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4S3P30JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARI","FLNC","KO","FIS","PPG","HUM","FRSH","MNST","CFLT","COTY","LU2279689827.SGD","POST","UNM","SMCI","VRTX","INSP","LDOS","MOH","GILD","TVTX","BK4504","KDP","MET","BYD","GL","AFL","PCG","LYFT","LNC","LH","WCC","L","EDR","ADPT","MAR","ST","CNA","DASH","EQH","LU1066051498.USD","PRU","ECL","CG","VST","CELH","PFG","ALSN","EIX","CNO","OS"],"gpt_icon":0},{"id":"2510345742","title":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2510345742","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510345742?lang=zh_cn&edition=full","pubTime":"2025-02-12 15:21","pubTimestamp":1739344887,"startTime":"0","endTime":"0","summary":"美国研究综述-爱迪生国际公司、Onestream 公司、Vertex 制药公司路透2月12日 - 华尔街证券分析师周三修订了对爱迪生国际、Onestream 和 Vertex Pharmaceuticals 等几家美国上市公司的评级和目标价。要点 * 爱迪生国际EIX.N:摩根大通给予其中性评级 * Molina Healthcare Inc MOH.N:摩根大通将目标价从350美元下调至333美元 * Onestream Inc OS.O:摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Vertex Pharmaceuticals Inc VRTX.O:Canaccord Genuity将其评级从 \"卖出 \"上调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4T3P30JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MET","ALSN","GL","FLNC","FRSH","PPG","MNST","MAR","KDP","CNO","ADPT","HUM","LU1066051498.USD","LNC","EIX","EQH","ARI","LDOS","OS","FIS","ECL","MOH","AFL","BYD","WCC","PFG","POST","EDR","LYFT","LU2279689827.SGD","ST","BK4504","VRTX","LH","CG","CNA","PCG","L","PRU","INSP","DASH","TVTX","UNM","CFLT","GILD","COTY"],"gpt_icon":1},{"id":"2510472920","title":"徕博科2024财年实现净利润7.46亿美元,同比增加96.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510472920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510472920?lang=zh_cn&edition=full","pubTime":"2025-02-10 00:00","pubTimestamp":1739116854,"startTime":"0","endTime":"0","summary":"2月10日,徕博科公布财报,公告显示公司2024财年净利润为7.46亿美元,同比增加96.83%;其中营业收入为130.09亿美元,同比增加6.96%,每股基本收益为8.89美元。从资产负债表来看,徕博科总负债103.13亿美元,其中短期债务11.85亿美元,资产负债比为1.79,流动比率为1.45。机构评级:截至2025年2月10日,当前有16家机构对徕博科目标价做出预测,其中目标均价为271.81美元,其中最低目标价为240.00美元,最高目标价为293.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210000129abc86720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210000129abc86720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LH"],"gpt_icon":0},{"id":"2509777981","title":"巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由271.00美元调整至260.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509777981","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509777981?lang=zh_cn&edition=full","pubTime":"2025-02-08 06:27","pubTimestamp":1738967224,"startTime":"0","endTime":"0","summary":"巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由271.00美元调整至260.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08062748031987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LH"],"gpt_icon":0},{"id":"2509773590","title":"杰富瑞投资银行:维持Labcorp Holdings(LH.US)评级,由买入调整至买入评级, 目标价由275.00美元调整至290.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509773590","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509773590?lang=zh_cn&edition=full","pubTime":"2025-02-07 07:26","pubTimestamp":1738884368,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行:维持Labcorp Holdings(LH.US)评级,由买入调整至买入评级, 目标价由275.00美元调整至290.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07072648003359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LH"],"gpt_icon":0},{"id":"1191052054","title":"Labcorp第四季度财报:收入和每股收益超预期,预计2025年将实现强劲增长,分析师重申“表现优异”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1191052054","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191052054?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:24","pubTimestamp":1738866295,"startTime":"0","endTime":"0","summary":"周四,Laboratory Corp报告其2024年第四季度调整后的每股收益为3.45美元,高于去年同期的3.30美元,超出市场预期的3.39美元。销售额同比增长9.8%,达到33.3亿美元,几乎与市场预期的33.1亿美元一致。调整后的季度运营收入为423.2百万美元,占收入的12.7%,而上一年同期为394.9百万美元,占收入的13%。这使得该股票在2025年具有稳定的指导性,并有可能在公司动能持续时获得收益。William Blair重申“表现优异”评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH"],"gpt_icon":0},{"id":"2509931274","title":"Labcorp Holdings Inc 报告截至 12 月 31 日的季度业绩 - 盈利摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2509931274","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509931274?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852340,"startTime":"0","endTime":"0","summary":"Labcorp Holdings Inc 报告截至 12 月 31 日的季度业绩 - 盈利摘要Labcorp Holdings Inc LH.N公布的截至12月31日的季度调整后每股收益为3.45美元,高于去年同期的每股收益3.30美元。Labcorp Holdings Inc公布的本季度每股收益为1.70美元。公司报告的季度净收入为1.434亿美元。本季度,Labcorp Holdings Inc 的股价上涨了 9.0%。华尔街对 Labcorp Holdings Inc 的 12 个月目标价中位数为 270.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nL4T3OX1KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4550","LH","LU0006061336.USD","LU1059921491.USD","BK4196"],"gpt_icon":0},{"id":"1174528505","title":"实验室公司2024年第四季度调整后每股收益为3.45美元,超过预期的3.39美元,销售额为33.3亿美元,超过预期的33.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174528505","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174528505?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:54","pubTimestamp":1738842871,"startTime":"0","endTime":"0","summary":"相较于去年同期每股收益3.30美元,这是一个4.55%的增长。公司报告季度销售额为33.3亿美元,超过分析师普遍预期的33.1亿美元,超出0.63%。以上内容来自Benzinga Earnings专栏,原文如下:Laboratory Corp reported quarterly earnings of $3.45 per share which beat the analyst consensus estimate of $3.39 by 1.77 percent. This is a 4.55 percent increase over earnings of $3.30 per share from the same period last year. The company reported quarterly sales of $3.33 billion which beat the analyst consensus estimate of $3.31 billion by 0.63 percent. This is a 9.76 percent increase o","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH"],"gpt_icon":0},{"id":"1149955265","title":"Labcorp预计2025年销售额为138.8亿至140.5亿美元,对比市场预期的137.9亿美元,调整后每股收益为15.60至16.40美元,对比市场预期的16.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149955265","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149955265?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:54","pubTimestamp":1738842859,"startTime":"0","endTime":"0","summary":"2025年指引假设外汇汇率截至2024年12月31日的全年有效。企业层面的指引包括当前预期的资本配置影响,包括收购、股票回购和股息。2024年Labcorp企业的收入为130.1亿美元,诊断实验室收入为101.4亿美元,生物制药实验室服务收入为29.2亿美元。调整后每股收益在2024年为14.57美元,2025年指引为15.60至16.40美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Labcorp预计2025年销售额为138.8亿至140.5亿美元,对比市场预期的137.9亿美元,调整后每股收益为15.60至16.40美元,对比市场预期的16.02美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH"],"gpt_icon":0},{"id":"2509224290","title":"由于诊断检测需求旺盛,Labcorp 预测 2025 年收入高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2509224290","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509224290?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:51","pubTimestamp":1738842717,"startTime":"0","endTime":"0","summary":"路透2月6日 - Labcorp LH.N周四公布的第四季度业绩超出华尔街预期,预计2025年的收入将高于华尔街预期,这主要得益于对其诊断测试的强劲需求。该公司预计 2025 年调整后利润为每股 15.60 美元至 16.40 美元,中间值与预期一致,为每股 16.02 美元。经调整后,Labcorp 在截至 12 月 31 日的这一季度实现每股利润 3.45 美元,高于预期的 3.39 美元。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nL4T3OX131:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","LU1854103824.USD","BK4588","LH","LU1059921491.USD","BK4583","LU0006061336.USD","LU1854104046.USD","BK4550","BK4567","DGX"],"gpt_icon":0},{"id":"2508218061","title":"巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由249.00美元调整至271.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508218061","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508218061?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:19","pubTimestamp":1738606781,"startTime":"0","endTime":"0","summary":"巴克莱:维持Labcorp Holdings(LH.US)评级,由持股观望调整至持股观望评级, 目标价由249.00美元调整至271.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04021947942460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LH"],"gpt_icon":0},{"id":"2507624791","title":"BUZZ-Quest 季度业绩超出预期,创三年新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624791","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507624791?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:07","pubTimestamp":1738249661,"startTime":"0","endTime":"0","summary":"1月30日 - ** 实验室运营商Quest Diagnostics DGX.N股价上涨7%,创下166.39美元的三年多新高 ** 该公司第四季度每股收益为2.23美元,超出华尔街预期的2.19美元--数据由LSEG编译。** DGX 第四季度营收为 26.2 亿美元,高于预期的 25.8 亿美元。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nL3S3OQ1HA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH","LU1854104046.USD","BK4567","BK4585","DGX","LU0006061336.USD","LU1854103824.USD","BK4196","BK4588","BK4550","BK4583"],"gpt_icon":0},{"id":"2507244696","title":"徕博科盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507244696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507244696?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:59","pubTimestamp":1738249143,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时59分,徕博科股票出现波动,股价大幅上涨5.02%。截至发稿,该股报258.59美元/股,成交量7.1283万股,换手率0.09%,振幅4.98%。徕博科股票所在的生命科学行业中,整体涨幅为3.94%。徕博科公司简介:徕博科控股有限公司是美国最大的两家独立临床实验室之一,拥有大约20%的独立实验室市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225904a23459db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225904a23459db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4585","LU0006061336.USD","BK4550","LH","BK4588"],"gpt_icon":0},{"id":"2504479897","title":"联环药业(600513.SH):1类新药LH-1801片Ⅲ期联合二甲双胍临床试验完成受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2504479897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504479897?lang=zh_cn&edition=full","pubTime":"2025-01-20 17:09","pubTimestamp":1737364155,"startTime":"0","endTime":"0","summary":"智通财经APP讯,联环药业(600513.SH)发布公告,公司组织开展的1类新药LH-1801片Ⅲ期联合二甲双胍临床试验于近日完成受试者入组。LH-1801片是一种新型SGLT2抑制剂,是由公司与中国科学院上海药物研究所合作开发的1类具有我国自主知识产权的抗糖尿病新药,具有良好的体内降血糖作用,适应症为2型糖尿病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","600513","03347","LH","BK4550","BK1583","BK4585","BK4196","BK1141","LU0006061336.USD","BK4588","BK0239"],"gpt_icon":0},{"id":"2501874387","title":"Evercore ISI Group:上调Labcorp Holdings评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2501874387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501874387?lang=zh_cn&edition=full","pubTime":"2025-01-08 00:27","pubTimestamp":1736267242,"startTime":"0","endTime":"0","summary":"evercore ISI Group:上调Labcorp Holdings(LH.US)评级,由大市同步调整至优于大市评级,目标价由260.00美元调整至265.00美元。徕博科(LH.US)公司简介:徕博科控股公司从事医疗检测服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108003541a21902d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108003541a21902d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVR","LH"],"gpt_icon":0},{"id":"2501678111","title":"Evercore ISI Group:上调Labcorp Holdings(LH.US)评级,由大市同步调整至优于大市评级, 目标价由260.00美元调整至265.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501678111","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501678111?lang=zh_cn&edition=full","pubTime":"2025-01-08 00:14","pubTimestamp":1736266451,"startTime":"0","endTime":"0","summary":"Evercore ISI Group:上调Labcorp Holdings(LH.US)评级,由大市同步调整至优于大市评级, 目标价由260.00美元调整至265.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/08001447233894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EVR","LH"],"gpt_icon":0},{"id":"2484641261","title":"Cinven 获意大利批准向 Labcorp 出售 Synlab 少数股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2484641261","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484641261?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:19","pubTimestamp":1732094343,"startTime":"0","endTime":"0","summary":"Cinven 获意大利批准向 Labcorp 出售 Synlab 少数股权路透罗马11月20日 - 一份提交给议会的政府文件显示,私募股权公司Cinven向实验室运营商Labcorp LH.N出售诊断服务提供商Synlab 15%股份的计划获得了意大利当局的有条件批准。金权法规定,任何导致该国战略资产的所有权、控制权或可用性发生变化的决策都必须获得意大利政府的批准。文件显示,意大利内阁于 11 月 12 日批准了这项交易,但附带了一些未明确说明的条件。该交易于 9 月份宣布,价值约 1.5 亿欧元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4550","LH","LU0006061336.USD","BK4196"],"gpt_icon":0},{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":" 路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻 * Apellis Pharmaceuticals Inc :摩根大通将目标价从57美元下调至50美元 * Chord Energy Corp :加拿大皇家银行将目标价从185美元下调至180美元 * Energizer Holdings Inc :摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2286300806.USD","CRM","LU1988902786.USD","FSUN","LH","BK4187","BK4086","LU2756315318.SGD","LU0265550946.USD","BK4596","LU0310799852.SGD","DYN","OCSL","TVTX","PBF","BK4579","ANNX","IE00BZ1G4Q59.USD","LU0006061336.USD","SWTX","CHRD","AZEK","AVAV","LU1951198990.SGD","NUVL","PIII","VIR","LU1267930490.SGD","CASY","WMT","BBIO","ENR","BERY","APLS","OLMA","IE00B19Z8X17.USD","VERA","MNPR","BRBR","LOW","BK4528","NOG","LU1551013425.SGD","IIIV","LU1066053197.SGD","LU2430703251.USD","LU0528227936.USD","VVV","BK4505","ABUS"],"gpt_icon":0},{"id":"2484194184","title":"BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休","url":"https://stock-news.laohu8.com/highlight/detail?id=2484194184","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484194184?lang=zh_cn&edition=full","pubTime":"2024-11-19 21:23","pubTimestamp":1732022620,"startTime":"0","endTime":"0","summary":"BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休11月19日 - ** 实验室服务提供商Labcorp控股公司LH.N股价盘前下跌1.7%,至234.49美元 ** 该公司表示,Julia Wang将接替Glenn Eisenberg担任首席财务官,12月2日生效,因为现任首席财务官在担任该职位十多年后将退休 ** Wang最近在生物技术公司BeiGene担任首席财务官,此前曾在Alexion制药公司和强生公司任职。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4T3MQ16B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1506573853.SGD","LU1778281490.HKD","LU1196500208.SGD","LU0345769128.USD","IE00BJT1NW94.SGD","IE000M9KFDE8.USD","LU1914381329.SGD","LU0114720955.EUR","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","LU0006061336.USD","LU1585245621.USD","LU2089984988.USD","LU0098860793.USD","LU0345770308.USD","LU1280957306.USD","BK4196","IE0034235303.USD","BK4588","LU2347655156.SGD","LU0122379950.USD","LU1894683348.USD","LU1244550577.SGD","LH","LU1162221912.USD","LU1244550221.USD","BK4532","IE00B3PB1722.GBP","LU1032466523.USD","LU1221951129.SGD","IE0002270589.USD","LU0234572021.USD","BK4592","IE00B19Z3581.USD","LU0234570918.USD","JNJ","LU1732799900.SGD","LU1935042991.SGD","SG9999002232.USD","LU1066051811.HKD","LU1894683264.USD","LU1066051225.USD","LU0466842654.USD","IE00B42XCP33.USD","IE00B2B36J28.USD","688235","LU1066053197.SGD","LU0640476718.USD","LU1244550494.USD","BK0239"],"gpt_icon":0},{"id":"2480670058","title":"徕博科2024财年第三财季实现净利润1.69亿美元,同比减少7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480670058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480670058?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:00","pubTimestamp":1730390428,"startTime":"0","endTime":"0","summary":"11月1日,徕博科公布财报,公告显示公司2024财年第三财季净利润为1.69亿美元,同比减少7.65%;其中营业收入为32.82亿美元,同比增加7.36%,每股基本收益为2.02美元。从资产负债表来看,徕博科总负债104.27亿美元,其中短期债务15.91亿美元,资产负债比为1.79,流动比率为1.44。机构评级:截至2024年11月1日,当前有16家机构对徕博科目标价做出预测,其中目标均价为263.69美元,其中最低目标价为231.00美元,最高目标价为293.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101000032ab8c4381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101000032ab8c4381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.labcorp.com","stockEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0324},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.07},{"period":"1year","weight":0.1369},{"period":"ytd","weight":0.074}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0233},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.0994},{"period":"1year","weight":0.2242},{"period":"ytd","weight":0.0434}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Labcorp Holdings Inc.是特拉华州的一家公司,成立于1971年。公司是一家领先的全球生命科学公司,已在指导患者护理方面深入整合。公司通过其LabCorp诊断(LCD)和Covance药物开发(CDD)部门提供全面的临床实验室和端到端药物开发服务。LabCorp定位于研究和护理交付的融合,以实现更精确和个性化的医疗保健,将世界一流的诊断和药物开发能力结合在一起。","yearOnYearQuotes":[{"month":1,"riseRate":0.633333,"avgChangeRate":0.025129},{"month":2,"riseRate":0.566667,"avgChangeRate":0.023007},{"month":3,"riseRate":0.655172,"avgChangeRate":-0.002971},{"month":4,"riseRate":0.689655,"avgChangeRate":0.055853},{"month":5,"riseRate":0.482759,"avgChangeRate":0.007381},{"month":6,"riseRate":0.566667,"avgChangeRate":0.0245},{"month":7,"riseRate":0.5,"avgChangeRate":0.009606},{"month":8,"riseRate":0.433333,"avgChangeRate":-0.033552},{"month":9,"riseRate":0.433333,"avgChangeRate":-0.004911},{"month":10,"riseRate":0.566667,"avgChangeRate":0.000399},{"month":11,"riseRate":0.666667,"avgChangeRate":0.006973},{"month":12,"riseRate":0.733333,"avgChangeRate":0.017165}],"exchange":"NYSE","name":"徕博科","nameEN":"Labcorp Holdings Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.1","shortVersion":"4.31.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"徕博科(LH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供徕博科(LH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"徕博科,LH,徕博科股票,徕博科股票老虎,徕博科股票老虎国际,徕博科行情,徕博科股票行情,徕博科股价,徕博科股市,徕博科股票价格,徕博科股票交易,徕博科股票购买,徕博科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"徕博科(LH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供徕博科(LH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}